I agree that content from Twitter will be displayed to me.
head of group
His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.
Contact hours for students: Monday 13:00, send an e-mail to arrange an appointment at least three days in advance!
Cseke, A, Schwarz, T, Jain, S, Decker, S, Vogl, K, Urban, E & Ecker, G 2020, 'Propafenone analogue with additional H‐bond acceptor group shows increased inhibitory activity on P‐glycoprotein', Archiv der Pharmazie. doi.org/10.1002/ardp.201900269
Girardi, E, César-Razquin, A, Lindinger, S, Papakostas, K, Konecka, J, Hemmerich, J, Kickinger, S, Kartnig, F, Gürtl, B, Klavins, K, Sedlyarov, V, Ingles-Prieto, A, Fiume, G, Koren, A, Lardeau, C-H, Kumaran Kandasamy, R, Kubicek, S, Ecker, GF & Superti-Furga, G 2020, 'A widespread role for SLC transmembrane transporters in resistance to cytotoxic drugs', Nature Chemical Biology. doi.org/10.1038/s41589-020-0483-3
Niello, M, Cintulova, D, Hellsberg, E, Jäntsch, K, Holy, M, Ayatollahi, LH, Cozzi, NV, Freissmuth, M, Sandtner, W, Ecker, GF, Mihovilovic, MD & Sitte, HH 2019, 'para-Trifluoromethyl-methcathinone is an allosteric modulator of the serotonin transporter', Neuropharmacology, vol. 161, 107615. doi.org/10.1016/j.neuropharm.2019.04.021
Kickinger, S, Hellsberg, E, Frølund, B, Schousboe, A, Ecker, GF & Wellendorph, P 2019, 'Structural and molecular aspects of betaine-GABA transporter 1 (BGT1) and its relation to brain function', Neuropharmacology, vol. 161, 107644. doi.org/10.1016/j.neuropharm.2019.05.021
Eichsteininger, J, Kirisits, K, Smöch, C, Stadlbauer, C, Nguyen, CH, Jäger, W, Özmen, A, Ecker, G, Krupitza, G & Krenn, L 2019, 'Structural insight into the in vitro anti-intravasative properties of flavonoids', Scientia Pharmaceutica, vol. 87, no. 3, 23. doi.org/10.3390/scipharm87030023